Factors Associated With Benefit of Treatment of Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis
Context: There is an ongoing debate on the optimal management of patent ductus arteriosus (PDA) in preterm infants. Identifying subgroup of infants who would benefit from pharmacological treatment might help.Objective: To investigate the modulating effect of the differences in methodological quality...
Saved in:
Main Authors: | Esther J. S. Jansen (Author), Tim Hundscheid (Author), Wes Onland (Author), Elisabeth M. W. Kooi (Author), Peter Andriessen (Author), Willem P. de Boode (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Conservative Management of Patent Ductus Arteriosus in Preterm Infants-A Systematic Review and Meta-Analyses Assessing Differences in Outcome Measures Between Randomized Controlled Trials and Cohort Studies
by: Tim Hundscheid, et al.
Published: (2021) -
Patent Ductus Arteriosus in Preterm Infants
by: Jia-Yuh Chen
Published: (2012) -
Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial)
by: Tim Hundscheid, et al.
Published: (2018) -
THE MODERN VIEW ON PATENT DUCTUS ARTERIOSUS IN PRETERM INFANTS
by: Жанна Анатольевна Звягина, et al.
Published: (2018) -
Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants
by: Caterina Coviello, et al.
Published: (2020)